Patents Assigned to Paracure, Inc.
  • Therapeutic uses of arglabin in combination with other chemotherapy agents
    Patent number: 6770673
    Abstract: Compositions and kits containing a first chemotherapeutic agent that includes arglabin or a derivative thereof and a second chemotherapeutic agent are described. The compositions and kits are effective for treating cancer in a human patient. Methods for suppressing tumor growth in a human and for reducing the immunodepressive effects of chemotherapeutic agents are also described.
    Type: Grant
    Filed: February 1, 1999
    Date of Patent: August 3, 2004
    Assignee: Paracure, Inc.
    Inventor: Sergazy M. Adekenov
  • Pharmaceutical compositions of arglabin and arglabin derivatives
    Patent number: 6693127
    Abstract: Pharmaceutical compositions containing arglabin and arglabin derivatives are described. The compositions can be in unit dosage form and are useful for the treatment of cancer in humans.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: February 17, 2004
    Assignee: Paracure, Inc.
    Inventor: Sergazy M. Adekenov
  • Arglabin compounds and therapeutic uses thereof
    Patent number: 6197767
    Abstract: The invention provides various derivatives of arglabin, a sesquiterpene lactone isolated from Artemisia glabella. These compounds are effective for suppressing tumor growth in mammals. A method of suppressing tumor growth in humans is also described.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: March 6, 2001
    Assignee: Paracure, Inc.
    Inventor: Sergazy M. Adekenov
  • Arglabin compounds and therapeutic uses thereof
    Patent number: 6080741
    Abstract: The invention provides various derivatives of arglabin, a sesquiterpene lactone isolated from Artemisia glabella. These compounds are effective for suppressing tumor growth in mammals. A method of suppressing tumor growth in humans is also described.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: June 27, 2000
    Assignee: Paracure, Inc.
    Inventor: Sergazy M. Adekenov
  • Arglabin compounds and therapeutic uses thereof
    Patent number: 6020365
    Abstract: The invention provides various derivatives of arglabin, a sesquiterpene lactone isolated from Artemisia glabella. These compounds are effective for suppressing tumor growth in mammals. A method of suppressing tumor growth in humans is also described.
    Type: Grant
    Filed: October 7, 1998
    Date of Patent: February 1, 2000
    Assignee: Paracure, Inc.
    Inventor: Sergazy M. Adekenov
  • Arglabin compounds and therapeutic uses thereof
    Patent number: 5902809
    Abstract: The invention provides various derivatives of arglabin, a sesquiterpene lactone isolated from Artemisia glabella. These compounds are effective for suppressing tumor growth in mammals. A method of suppressing tumor growth in humans is also described.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: May 11, 1999
    Assignee: Paracure, Inc.
    Inventor: Sergazy M. Adekenov